GWAS |
- Brain imaging measurements (variance) ( 32047264)
- Cardiac hypertrophy ( 21348951)
- Psychosis proneness (hypomanic personality scale and revised social anhedonia scale) ( 28525603)
|
- Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced) ( 24236485)
- Adverse response to chemotherapy (amenorrhea) in breast cancer ( 31371054)
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Autism spectrum disorder or schizophrenia ( 28540026)
- Bipolar disorder ( 33263727 31043756)
- Chronotype ( 30696823)
- Cognitive performance ( 20125193)
- LDL levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder ( 33824429)
- Lung cancer ( 28604730)
- Lung cancer in never smokers ( 28604730)
- Parkinson's disease or first degree relation to individual with Parkinson's disease ( 31701892)
- Refractive error ( 32231278)
- Response to mTOR inhibitor (rapamycin) ( 24009623)
- Rosacea symptom severity ( 29771307)
- Schizophrenia ( 25056061 29483656 30285260)
- Squamous cell lung carcinoma ( 28604730)
- Total cholesterol levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder ( 33824429)
- Triglyceride levels ( 32203549)
|